GlassScriptPhysician profile
Matthew Cronin
NPI 1821103714
$7,485.24
in general payments reported to CMS, 2019-2025
9 companies · $35.25 in 2025
The $35.25 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,788 · 2021: $58.56 · 2022: $1,356 · 2023: $248 · 2025: $35.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235 · Travel and Lodging: $48.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.14 |
| Travel and Lodging | $48.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,016.20 | 2019 | |
| Philips North America LLC | $1,604.11 | 2019 | |
| Medical Device Business Services, INC. | $1,208.07 | 2019 | |
| Medtronic, INC. | $1,089.85 | 2021-2022 | |
| Terumo Medical Corporation | $959.14 | 2019 | |
| Inari Medical, INC. | $455.92 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $104.04 | 2022 | |
| Medline Industries LP | $35.25 | 2025 | |
| Boston Scientific Corporation | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.